🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the effects of rosuvastatin compared...
Status
Completed
Location
Research site
Start Date
2002-11
Trial ID
NCT00800800
Treatments Being Tested
The relation between improvement in results of treating spontaneous intrace...
Status
Completed
Location
Pomeranian Medical University
Start Date
2017-03-17
Trial ID
NCT06094244
Treatments Being Tested
The purpose of this study is to measure the effect of ticagrelor on the pha...
Status
Completed
Location
Research Site
Start Date
2024-08-05
Trial ID
NCT06554821
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
HILLCLIMBER is a randomized, controlled, open-label phase II trial of moder...
Status
Completed
Location
Northwestern University
Start Date
2016-11
Trial ID
NCT02841774
Treatments Being Tested
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
The purpose of this study is to assess the effect of the coadministration o...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-05
Trial ID
NCT02234882
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of Olostar Table...
Status
Active Not Recruiting
Location
Severance Hospital
Start Date
2022-06-20
Trial ID
NCT05411887
Treatments Being Tested
This is a study to evaluate the effect on LDL-C and the safety and tolerabi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-17
Trial ID
NCT07619131
This study will assess the safety, tolerability, pharmacokinetics (PK), and...
Status
Completed
Location
Research Site
Start Date
2022-05-18
Trial ID
NCT05384262